Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Satish Krishnan, MBBS, MRCP, FRCPath, Huihua Li, Yasser R Abou Mourad, Michael J. Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna E. Hogge, MD, PhD

Blood (2011) 118 (21): 2561.

https://doi.org/10.1182/blood.V118.21.2561.2561

Published: 2011

Journal Articles

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Cynthia L. Toze, MD, FRCPC, Chinmay B. Dalal, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, Yasser Abou Mourad, MD, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, FRCPath, Sujaatha Narayanan, MD, Tanya L. Gillan, PhD, FCCMG, Clayton A. Smith, MD, FRCPC, John D. Shepherd, MD, FRCPC

Blood (2011) 118 (21): 3100.

https://doi.org/10.1182/blood.V118.21.3100.3100

Published: 2011

Journal Articles

Safety and Efficacy of Posaconazole for the Treatment of Invasive Fungal Infections After Failure of One Prior Line of Therapy

Shariq Haider, MD FRCPC FACP CCST(UK), Laverdiere Michel, MD, Maryse M. Power, MD, FRCPath, Coleman Rotstein, MD, FRCPC, FACP, Shahid Husain, MD, MS, Jeffrey H. Lipton, MD, PhD, Karen Doucette, FRCPC, MSc, Peter Phillips, MD FRCPC, Andre Galarneau, Jean-Francois Pouliot, PhD

Blood (2011) 118 (21): 4479.

https://doi.org/10.1182/blood.V118.21.4479.4479

Published: 2011

Journal Articles

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Alina S. Gerrie, MD, FRCPC, Maryse M. Power, MD, FRCPath, Kerry J. Savage, MD MSc, John D. Shepherd, MD, FRCPC, Joseph M. Connors, MD

Blood (2011) 118 (21): 2022.

https://doi.org/10.1182/blood.V118.21.2022.2022

Published: 2011

Journal Articles

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Adisak Tantiworawit, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna L. Forrest, MD

Blood (2011) 118 (21): 1694.

https://doi.org/10.1182/blood.V118.21.1694.1694

Published: 2011

Journal Articles

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Derek To, Dawn Warkentin, BSc(Pharm), PharmD, Raewyn Broady, MBChB, FRACP, Kevin Song, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, John D. Shepherd, MD, FRCPC, Donna E. Hogge, MD, PhD, Cynthia L. Toze, MD, FRCPC, Sujaatha Narayanan, MD, Yasser Abou Mourad, MD, Heather J. Sutherland, MD, PhD, FRCPC, Maryse M. Power, MD, FRCPath

Blood (2011) 118 (21): 4567.

https://doi.org/10.1182/blood.V118.21.4567.4567

Published: 2011

NARROW

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Safety and Efficacy of Posaconazole for the Treatment of Invasive Fungal Infections After Failure of One Prior Line of Therapy

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Email alerts

ASH Publications

American Society of Hematology

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Safety and Efficacy of Posaconazole for the Treatment of Invasive Fungal Infections After Failure of One Prior Line of Therapy

Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only